Short course of high dose steroids used for non-pulmonary indication like anaphylaxis caused flare up of tuberculosis & presenting as acute pulmonary tuberculosis with pleural effusion: a case report
More details
Hide details
Venkatesh Chest Hospital & Assistant Professor, Pulmonary Medicine, MIMSR Medical College, Latur, India
Internal Medicine, MIMSR Medical College, Latur, India
Online publication date: 2017-12-29
Publication date: 2018-01-03
Corresponding author
Shital Patil   

Assistant Professor & Head, Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra State, India Phone: +917719036449, +919527028888
Eur J Gen Med 2018;15(1):37-42
Tuberculosis (TB) remains a major health problem in India, and accounts for nearly 20-30% of the global TB burden. Prevalence of tuberculosis infection in India is 40%, with pulmonary tuberculosis accounts for 80% cases, and in immune-competent individuals 5 to 10% chance of TB progressing from infection to disease during their lifetimes. Data is available for possible role of steroids used for pulmonary and non-pulmonary indications in increasing risk of new tuberculosis infection, reactivation of latent tuberculosis infection and relapse of treated disease. In this case report, 25 year male received high dose intravenous steroids for life threatening anaphylaxis because of bee sting bite only for four days caused reactivation of latent tuberculosis infection (LTBI). Clinical presentation is acute form of progressive pulmonary tuberculosis with pleural effusion which can be misdiagnosed as a community acquired pneumonia. High index of suspicion with adequate evaluation is must in all cases to have satisfactory treatment outcome.
Surpal BB. Magnitude of tuberculosis problem in India. J Ind Med Assoc. 1989;87:201.
American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221−S247.
Munck A, Mendel DB, Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Respir. Dis. 1990;141:82.
Trehan AP, Ahmed A. Corticosteroids: a review with emphasis on complication of prolonged systemic therapy. Ann Allergy. 1989;62:375.
Tam LS, Li EK, Wong SM, Szeto CC. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol. 2002;31:296-300.
Wilson CB. The cellular immune system and its role in host defence. In: Mandel GL, Douglas RG Jr., Bennett JE: Eds. Principles and Practice of Infectious Disease. New York: Churchill Livingstone. 1990;101.
Mitsos L, Sasseville D. Systemic corticosteroid use in dermatology: defining, detailing, and demystifying. Dermatol Rounds. 2012;7-2.
Pal D, Behera D, Gupta D, Aggarwal A. Tuberculosis in patients receiving prolonged treatment with oral corticosteroids for respiratory disorders. Indian J Tub. 2002;49:83.
Journals System - logo
Scroll to top